Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus

Author： Chong Benjamin F   Mohan Chandra  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.13, Iss.10, 2009-10, pp. : 1147-1153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 13, 2016-05 ,pp. : 1441-1451

Bentham Science Publishers

Access to resources Recommend Favorite

CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization

By  

Current Pharmaceutical Design, Vol. 16, Iss. 35, 2010-12 ,pp. : 3903-3920

Bentham Science Publishers

Access to resources Recommend Favorite

The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection

By  

Current Medicinal Chemistry, Vol. 18, Iss. 4, 2011-02 ,pp. : 497-512

Bentham Science Publishers

Access to resources Recommend Favorite

CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment

By  

Current Pharmaceutical Design, Vol. 21, Iss. 17, 2015-05 ,pp. : 2276-2283

Bentham Science Publishers

Access to resources Recommend Favorite

CXCR4-CXCL12-Dependent Inflammatory Network and Endothelial Progenitors

By  

Current Medicinal Chemistry, Vol. 17, Iss. 27, 2010-09 ,pp. : 3019-3029

Bentham Science Publishers

Access to resources Recommend Favorite